Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomio Inoue

Showing results (281-290 of 303) with videos related to

Pageof 31
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 16, 2019
High molecular weight amyloid β<sub>1-42</sub> oligomers induce neurotoxicity <i>via</i> plasma membrane damageTaro Yasumoto, Yusaku Takamura, Mayumi Tsuji, et al.
Scientific Reports|July 30, 2021
In vitro monitoring of HTR2A-positive neurons derived from human-induced pluripotent stem cellsKento Nakai, Takahiro Shiga, Rika Yasuhara, et al.
Annals of Nuclear Medicine|October 23, 2012
The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide surveyRyogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
BMC Cancer|December 7, 2010
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary reportKazuhiro Namura, Ryogo Minamimoto, Masahiro Yao, et al.
Annals of Nuclear Medicine|September 17, 2021
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumorsNoritoshi Kobayashi, Shoko Takano, Kenichi Ito, et al.
Free Radical Biology & Medicine|May 20, 2021
Myricetin prevents high molecular weight Aβ<sub>1-42</sub> oligomer-induced neurotoxicity through antioxidant effects in cell membranes and mitochondriaAtsushi Michael Kimura, Mayumi Tsuji, Taro Yasumoto, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|September 10, 2004
[A questionnaire about radiation safety management of the draining-water system at nuclear medicine facilities]Kazuya Shizukuishi, Hiroshi Watanabe, Hiroto Narita, et al.
Annals of Nuclear Medicine|October 7, 2004
Clinical usefulness of ECG-gated 18F-FDG PET combined with 99mTC-MIBI gated SPECT for evaluating myocardial viability and functionYohei Yamakawa, Nobukazu Takahashi, Toshiyuki Ishikawa, et al.
Biomed Research International|October 26, 2018
Efficient Synthesis of Glutamate Peptide-Estradiol Conjugate for Imaging Estrogen Receptor-Positive DiseasesMing-Chi Shih, Sergio Daniel Simon, Zhiming Jin, et al.
BMC Cancer|May 4, 2012
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseDaiki Ueno, Masahiro Yao, Ukihide Tateishi, et al.
Pageof 31

Showing results (281-290 of 303) with videos related to

Sort By:
Pageof 31
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 16, 2019
High molecular weight amyloid β<sub>1-42</sub> oligomers induce neurotoxicity <i>via</i> plasma membrane damageTaro Yasumoto, Yusaku Takamura, Mayumi Tsuji, et al.
Scientific Reports|July 30, 2021
In vitro monitoring of HTR2A-positive neurons derived from human-induced pluripotent stem cellsKento Nakai, Takahiro Shiga, Rika Yasuhara, et al.
Annals of Nuclear Medicine|October 23, 2012
The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide surveyRyogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
BMC Cancer|December 7, 2010
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary reportKazuhiro Namura, Ryogo Minamimoto, Masahiro Yao, et al.
Annals of Nuclear Medicine|September 17, 2021
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumorsNoritoshi Kobayashi, Shoko Takano, Kenichi Ito, et al.
Free Radical Biology & Medicine|May 20, 2021
Myricetin prevents high molecular weight Aβ<sub>1-42</sub> oligomer-induced neurotoxicity through antioxidant effects in cell membranes and mitochondriaAtsushi Michael Kimura, Mayumi Tsuji, Taro Yasumoto, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|September 10, 2004
[A questionnaire about radiation safety management of the draining-water system at nuclear medicine facilities]Kazuya Shizukuishi, Hiroshi Watanabe, Hiroto Narita, et al.
Annals of Nuclear Medicine|October 7, 2004
Clinical usefulness of ECG-gated 18F-FDG PET combined with 99mTC-MIBI gated SPECT for evaluating myocardial viability and functionYohei Yamakawa, Nobukazu Takahashi, Toshiyuki Ishikawa, et al.
Biomed Research International|October 26, 2018
Efficient Synthesis of Glutamate Peptide-Estradiol Conjugate for Imaging Estrogen Receptor-Positive DiseasesMing-Chi Shih, Sergio Daniel Simon, Zhiming Jin, et al.
BMC Cancer|May 4, 2012
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseDaiki Ueno, Masahiro Yao, Ukihide Tateishi, et al.
Pageof 31